AIM
RMD icon

Artemis Investment Management’s ResMed RMD Stock Holding History

Artemis Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-40,988
Closed -$4.67M – 295
2018
Q4 		$4.67M Sell
40,988
-59,319
-59% -$6.36M 0.06% 215
2018
Q3 		$11.6M Buy
100,307
+684
+0.7% +$74.9K 0.13% 179
2018
Q2 		$10.3M Buy
+99,623
New +$10.1M 0.14% 151

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artemis Investment Management's RMD Position: Q1 2019 in Review

Artemis Investment Management sold out of ResMed (RMD) in Q1 2019, closing a stake of 40,988 shares — an estimated $4.67M sold.

Artemis Investment Management first reported a position in RMD in Q2 2018 and held it in 3 quarters. The position peaked at $11.6M in Q3 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

  • Artemis Investment Management reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
  • Artemis Investment Management sold 40,988 ResMed shares in Q1 2019, an estimated $4.67M.
  • Artemis Investment Management first reported a position in ResMed in Q2 2018 and held it in 3 quarters.
  • Artemis Investment Management's ResMed position peaked at $11.6M in Q3 2018.
  • 477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Artemis Investment Management's 13F filing for Q1 2019, filed 15 May 2019.